, Molecular Cell Biology, 2000.
Synthesis of Ribonucleosides and Diribonucleoside Phosphates Containing 2-Chloroethylamine and Nitrogen Mustard Residues, Tetrahedron Lett, vol.37, pp.3557-3562, 1967. ,
Sequence-Specific Crosslinking Agents for Nucleic Acids, J. Mol. Biol, vol.122, issue.2, pp.90032-90035, 1978. ,
Inhibition of Rous Sarcoma Virus Replication and Cell Transformation by a Specific Oligodeoxynucleotide, Proc. Natl. Acad. Sci. U. S. A, vol.75, issue.1, pp.280-284, 1978. ,
Inhibition of Rous Sarcoma Viral RNA Translation by a Specific Oligodeoxyribonucleotide, Proc. Natl. Acad. Sci. U. S. A, vol.75, issue.1, pp.285-288, 1978. ,
, Antisense Oligodeoxynucleotides and Antisense RNANovel Pharmacological and Therapeutic Agents, 1997.
Introduction of a Chimeric Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in Trans, Plant Cell, vol.2, issue.4, pp.279-289, 1990. ,
Potent and Specific Genetic Interference by Double-Stranded RNA in Caenorhabditis Elegans, Nature, vol.391, issue.6669, pp.806-811, 1998. ,
-Methoxy)Ethyl-Modified Anti-Intercellular Adhesion Molecule 1 (ICAM-1) Oligonucleotides Selectively Increase the ICAM-1 MRNA Level and Inhibit Formation of the ICAM-1 Translation Initiation Complex in Human Umbilical Vein Endothelial Cells, J. Biol. Chem, issue.2, pp.11994-12000, 1997. ,
Synthetic Polynucleotides and the Amino Acid Code, Proc. Natl. Acad. Sci. U. S. A, vol.47, pp.1936-1942, 1961. ,
Comparative Inhibition of Rabbit Globin MRNA Translation by Modified Antisense Oligodeoxynucleotides, Nucleic Acids Res, vol.17, issue.11, pp.4255-4273, 1989. ,
Antisense Oligonucleotides: From Design to Therapeutic Application, Clin. Exp. Pharmacol. Physiol, vol.33, issue.5-6, pp.533-540, 2006. ,
Fully Modified 2' MOE Oligonucleotides Redirect Polyadenylation, Nucleic Acids Res, vol.29, issue.6, pp.1293-1299, 2001. ,
A MicroRNA Component of the P53 Tumour Suppressor Network, Nature, vol.447, issue.7148, pp.1130-1134, 2007. ,
Suppression of Non-Small Cell Lung Tumor Development by the Let-7 MicroRNA Family, Proc. Natl. Acad. Sci. U. S. A, issue.10, pp.3903-3908, 2008. ,
,
Potent Inhibition of MicroRNA in Vivo without Degradation, Nucleic Acids Res, vol.37, issue.1, pp.70-77, 2009. ,
Mi-croRNA-143 Regulates Adipocyte Differentiation, J. Biol. Chem, issue.50, pp.52361-52365, 2004. ,
,
Inhibition of Human Telomerase Activity by Peptide Nucleic Acids, Nat. Biotechnol, vol.14, issue.5, pp.615-619, 1996. ,
,
Pharmacokinetics of Antisense Oligonucleotides, Clin. Pharmacokinet, vol.28, issue.1, pp.7-16, 1995. ,
An Exocyclic Methylene Group Acts as a Bioisostere of the 2'-Oxygen Atom in LNA, J. Am. Chem. Soc, issue.42, pp.14942-14950, 2010. ,
The Chemical Evolution of Oligonucleotide Therapies of Clinical Utility, Nat. Biotechnol, vol.2017, issue.3, pp.238-248 ,
RNA Interference and Chemically Modified Small Interfering RNAs, Curr. Opin. Chem. Biol, vol.8, issue.6, pp.570-579, 2004. ,
A Critical Survey of the Structure-Function of the Antisense Oligo/RNA Heteroduplex as Substrate for RNase H, J. Biochem. Biophys. Methods, vol.48, issue.3, pp.189-208, 2001. ,
, Antisense Strategies for Oncogene Inactivation. Semin. Oncol, vol.32, issue.6, pp.563-572, 2005.
Phosphoryl Guanidines: A New Type of Nucleic Acid Analogues, Acta Naturae, vol.6, issue.4, pp.116-118, 2014. ,
Modified Oligonucleotides and Methods for Their Synthesis, 2016. ,
Morpholino Antisense Oligomers: Design, Preparation, and Properties, Antisense Nucleic Acid Drug Dev, vol.7, issue.3, pp.187-195, 1997. ,
Gene Delivery by Lipoplexes and Polyplexes, Eur. J. Pharm. Sci, vol.2010, issue.3, pp.159-170 ,
Nonviral Vectors for Gene Delivery, Chem. Rev, vol.109, issue.2, pp.259-302, 2009. ,
,
Non-Viral Vectors for Gene-Based Therapy, Nat. Rev. Genet, vol.15, issue.8, pp.541-555, 2014. ,
Lipoplexes and Intracellular Delivery of Genes, J. Control. Release Off. J. Control. Release Soc, vol.116, issue.2, pp.255-264, 2006. ,
Balancing Cationic and Hydrophobic Content of PEGylated SiRNA Polyplexes Enhances Endosome Escape, Stability, Blood Circulation Time, and Bioactivity In Vivo, ACS Nano, issue.7, 2013. ,
The Fate of Poly(2-Dimethyl Amino Ethyl)Methacrylate-Based Polyplexes after Intravenous Administration, Int. J. Pharm, vol.214, issue.1, pp.642-648, 2001. ,
The Role of Tissue Macrophages in the Induction of Proinflammatory Cytokine Production Following Intravenous Injection of Lipoplexes, Gene Ther, vol.9, issue.16, pp.1120-1126, 2002. ,
,
Recent Developments in Nucleic Acid Delivery with Polyethylenimines, Adv. Genet, vol.88, pp.263-288, 2014. ,
Self-Aggregating 1.8kDa Polyethylenimines with Dissolution Switch at Endosomal Acidic PH Are Delivery Carriers for Plasmid DNA, MRNA, SiRNA and Exon-Skipping Oligonucleotides, J. Controlled Release, vol.246, pp.60-70, 2017. ,
A Novel Type of Self-Assembled Nanoparticles as Targeted Gene Carriers: An Application for Plasmid DNA and AntimicroRNA Oligonucleotide Delivery, Int. J. Nanomedicine, vol.11, pp.399-411, 2016. ,
,
, Gene Delivery Materials. Mater. Today, vol.2012, issue.9, pp.70165-70172
Polyion Complex Micelle Based on Albumin-Polymer Conjugates: Multifunctional Oligonucleotide Transfection Vectors for Anticancer Chemotherapeutics, Biomacromolecules, vol.15, issue.11, pp.4195-4205, 2014. ,
,
Oncolytic Adenoviruses in Anticancer Therapy: Current Status and Prospects, Mol. Biol, vol.2012, issue.4, pp.496-507 ,
,
Viral Vectors for Gene Therapy: Current State and Clinical Perspectives, Biochem. Biokhimiia, vol.81, issue.7, pp.700-708, 2016. ,
Viral Vectors for Gene Therapy and Gene Modification Approaches, Biochem. Eng. J, vol.108, pp.98-115, 2016. ,
Lipid Nanoparticles for Gene Delivery, Adv. Genet, vol.88, pp.13-36, 2014. ,
Systemic Administration of SiRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast Cancer, Mol. Pharm, 2018. ,
Acute and Chronic Shear Stress Differently Regulate Endothelial Internalization of Nanocarriers Targeted to Platelet-Endothelial Cell Adhesion Molecule-1, ACS Nano, vol.6, issue.10, pp.8824-8836, 2012. ,
Flow Shear Stress Differentially Regulates Endothelial Uptake of Nanocarriers Targeted to Distinct Epitopes of PECAM-1, J. Control. Release Off. J. Control. Release Soc, vol.210, pp.39-47, 2015. ,
PECAM-1 Directed Re-Targeting of Exogenous MRNA Providing Two Orders of Magnitude Enhancement of Vascular Delivery and Expression in Lungs Independent of Apolipoprotein E-Mediated Uptake, J. Control. Release Off. J. Control. Release Soc, vol.291, pp.106-115, 2018. ,
Lipid and Nucleic Acid Chemistries: Combining the Best of Both Worlds to Construct Advanced Biomaterials, Adv. Mater, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02374786
Self-Assembled Nucleolipids: From Supramolecular Structure to Soft Nucleic Acid and Drug Delivery Devices, Nucleic Acids Res, vol.40, issue.5, pp.1891-1903, 2012. ,
Nucleoside-Lipid-Based Nanoparticles for Cisplatin Delivery, ACS Nano, vol.5, issue.11, pp.8649-8655, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00696838
,
Cationic Nucleoside Lipids for Gene Delivery, Bioconjug. Chem, vol.17, issue.2, pp.466-472, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00165573
,
Nucleotide and Oligonucleotide Based Amphiphiles: A Successful Marriage of Nucleic Acids with Lipids, Org. Biomol. Chem, vol.6, issue.8, pp.1324-1333, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-02484364
Efficient Delivery of Therapeutic Small Nucleic Acids to Prostate Cancer Cells Using Ketal Nucleoside Lipid Nanoparticles, J. Control. Release Off. J. Control. Release Soc, vol.2013, issue.3, pp.954-961 ,
URL : https://hal.archives-ouvertes.fr/hal-00975040
,
Multivalent Cyclic RGD Conjugates for Targeted Delivery of Small Interfering RNA, Bioconjug. Chem, issue.8, pp.1673-1681, 2011. ,
Integrin Targeted Delivery of Gene Therapeutics, Theranostics, vol.1, pp.211-219, 2011. ,
Oligonucleotide Conjugates -Candidates for Gene Silencing Therapeutics, Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. Verfahrenstechnik, vol.107, pp.321-340, 2016. ,
,
Intracellular Delivery of an Antisense Oligonucleotide via Endocytosis of a G Protein-Coupled Receptor, Nucleic Acids Res, issue.19, pp.6567-6576, 2010. ,
Conjugation with Receptor-Targeted Histidine-Rich Peptides Enhances the Pharmacological Effectiveness of Antisense Oligonucleotides, Bioconjug. Chem, vol.25, issue.1, pp.165-170, 2014. ,
In Vivo Characterization of Four 68Ga-Labeled Multimeric RGD Peptides to Image ?v?3 Integrin Expression in Two Human Tumor Xenograft Mouse Models, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, 2018. ,
High Expression of Integrin ?v?3 Enables Uptake of Targeted Fluorescent Probes into Ovarian Cancer Cells and Tumors, Bioorg. Med. Chem, vol.26, issue.8, pp.2085-2091, 2018. ,
68Ga-BBN-RGD PET/CT for GRPR and Integrin ?v?3 Imaging in Patients with, Breast Cancer, vol.8, issue.4, pp.1121-1130, 2018. ,
Drug Delivery System of Therapeutic Oligonucleotides, Drug Discov. Ther, vol.10, issue.5, pp.256-262, 2016. ,
Efficient in Vivo Delivery of SiRNA to the Liver by Conjugation of Alpha-Tocopherol, Mol. Ther. J. Am. Soc ,
, Gene Ther, vol.16, issue.4, pp.734-740, 2008.
Chimeric Antisense Oligonucleotide Conjugated to ?-Tocopherol, Mol. Ther. Nucleic Acids, vol.4, issue.1, 2015. ,
Cell Type-Specific Delivery of SiRNAs with Aptamer-SiRNA Chimeras, Nat. Biotechnol, vol.24, issue.8, pp.1005-1015, 2006. ,
An Aptamer-SiRNA Chimera Suppresses HIV-1 Viral Loads and Protects from Helper CD4+ T Cell Decline in Humanized Mice, Sci. Transl. Med, vol.3, issue.66, 2011. ,
Cell-Type Specific Aptamer and Aptamer-SiRNA Conjugates for Targeted HIV-1 Therapy, J. Investig. Med. Off. Publ. Am. Fed. Clin. Res, vol.62, issue.7, pp.914-919, 2014. ,
,
Novel Dual Inhibitory Function Aptamer-SiRNA Delivery System for HIV-1 Therapy, Mol. Ther. J. Am. Soc. Gene Ther, vol.16, issue.8, pp.1481-1489, 2008. ,
Aptamer-SiRNA Chimeras: Discovery, Progress, and Future Prospects, Biomedicines, vol.2017, issue.3, p.45 ,
Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes, Int. J. Mol. Sci, vol.2017, issue.8, p.1683 ,
Antibody Mediated in Vivo Delivery of Small Interfering RNAs via Cell-Surface Receptors, Nat. Biotechnol, vol.23, issue.6, pp.709-717, 2005. ,
, Novel Targeted Therapy for Precursor B-Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate
, , vol.22, pp.632-642, 2016.
Systematic Evaluation of Antibody-Mediated SiRNA Delivery Using an Industrial Platform of THIOMAB-SiRNA Conjugates, Nucleic Acids Res, vol.43, issue.2, pp.1189-1203, 2015. ,
Lipid-Conjugated Oligonucleotides via "Click Chemistry, J. Med. Chem, issue.15, pp.4374-4376, 2008. ,
Carrier-Free Cellular Uptake and the Gene-Silencing Activity of the Lipophilic SiRNAs Is Strongly Affected by the Length of the Linker between SiRNA and Lipophilic Group, Nucleic Acids Res, vol.40, issue.5, pp.2330-2344, 2012. ,
Cholesterol-Containing Nuclease-Resistant SiRNA Accumulates in Tumors in a Carrier-Free Mode and Silences MDR1 Gene, Mol. Ther. Nucleic Acids, vol.6, pp.209-220, 2017. ,
,
Cholesterol-Modified Caged SiRNAs for Photoregulating Exogenous and Endogenous Gene Expression. Bioconjug. Chem, 2018. ,
Therapeutic Silencing of an Endogenous Gene by Systemic Administration of Modified SiRNAs, Nature, vol.432, issue.7014, pp.173-178, 2004. ,
Therapeutic Silencing of Mutant Huntingtin with SiRNA Attenuates Striatal and Cortical Neuropathology and Behavioral Deficits, Proc. Natl. Acad. Sci. U. S. A, vol.104, issue.43, pp.17204-17209, 2007. ,
Cholesterol-Modified Caged SiRNAs for Photoregulating Exogenous and Endogenous Gene Expression. Bioconjug. Chem, 2018. ,
Gene Silencing Activity and Hepatic Accumulation of Antisense Oligonucleotides Bearing Cholesterol-Conjugated Thiono Triester at the Gap Region. Nucleic Acid Ther, vol.27, pp.232-237, 2017. ,
Lung Delivery Studies Using SiRNA Conjugated to TAT(48?60) and Penetratin Reveal Peptide Induced Reduction in Gene Expression and Induction of Innate Immunity, Bioconjug. Chem, vol.18, issue.5, pp.1450-1459, 2007. ,
Lipid Conjugated Oligonucleotides: A Useful Strategy for Delivery, Bioconjug. Chem, vol.2012, issue.6, pp.1091-1104 ,
URL : https://hal.archives-ouvertes.fr/hal-02330037
Synthesis, Characterization, and in Vivo Delivery of SiRNA-Squalene Nanoparticles Targeting Fusion Oncogene in Papillary Thyroid Carcinoma, J. Med. Chem, vol.54, issue.12, pp.4067-4076, 2011. ,
Lipid Modification of GRN163, an N3? ? P5? Thio-Phosphoramidate Oligonucleotide, Enhances the Potency of Telomerase Inhibition, Oncogene, vol.24, issue.33, pp.5262-5268, 2005. ,
,
Telomerase Inhibitor Imetelstat (GRN163L) Limits the Lifespan of Human Pancreatic Cancer Cells, PLoS ONE, vol.2014, issue.1 ,
Lipid-Conjugated Telomerase Template Antagonists Sensitize Resistant HER2-Positive Breast Cancer Cells to Trastuzumab, Breast Cancer Res. Treat, vol.118, issue.1, pp.21-32, 2009. ,
Sensitive Liposomes Encoded with Oligonucleotide Amphiphiles: A Biocompatible Switch, Chem. Commun, issue.43, pp.5550-5552, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-02484276
Lipid Oligonucleotide Conjugates as Responsive Nanomaterials for Drug Delivery, J. Mater. Chem. B, vol.2013, issue.39, p.5329 ,
URL : https://hal.archives-ouvertes.fr/hal-02484550
Lipid-Oligonucleotide Conjugates Improve Cellular Uptake and Efficiency of TCTP-Antisense in Castration-Resistant Prostate Cancer, J. Controlled Re, vol.258, pp.1-9, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01520102
TCTP as Therapeutic Target in Cancers, Cancer Treat. Rev, vol.40, issue.6, pp.760-769, 2014. ,
Targeting TCTP as a New Therapeutic Strategy in Castration-Resistant Prostate Cancer, Mol. Ther, vol.2012, issue.12, pp.2244-2256 ,
,
Characterising the Castration-Resistant Prostate Cancer Population: A Systematic Review, Int. J. Clin. Pract, vol.65, issue.11, pp.1180-1192, 2011. ,
Amphiphilic Lipopeptide Significantly Enhances Uptake of Charge-Neutral Splice Switching Morpholino Oligonucleotide in Spinal Muscular Atrophy Patient-Derived Fibroblasts, Int. J. Pharm, vol.2017, issue.1, pp.21-28 ,
Cholesterol-GalNAc Dual Conjugation Strategy for Reducing Renal Distribution of Antisense Oligonucleotides, Nucleic Acid Ther, vol.28, issue.1, pp.50-57, 2018. ,
,
Serial Incorporation of a Monovalent GalNAc Phosphoramidite Unit into Hepatocyte-Targeting Antisense Oligonucleotides, Bioorg. Med. Chem, vol.24, issue.1, pp.26-32, 2016. ,
, Spherical Nucleic Acids. J. Am. Chem. Soc, vol.2012, issue.3, pp.1376-1391
,
Antibody-Linked Spherical Nucleic Acids for Cellular Targeting, J. Am. Chem. Soc, vol.2012, issue.40, pp.16488-16491 ,
, Immunomodulatory Spherical Nucleic Acids. Proc. Natl. Acad. Sci, vol.2015, issue.13, pp.3892-3897
,
Conjugation Chemistry-Dependent T-Cell Activation with Spherical Nucleic Acids, J. Am. Chem. Soc, vol.140, issue.4, pp.1227-1230, 2018. ,
Design Considerations for RNA Spherical Nucleic Acids (SNAs), Bioconjug. Chem, vol.27, issue.9, pp.2124-2131, 2016. ,
Locked Nucleic Acid-Nanoparticle Conjugates, ChemBioChem, vol.8, issue.11, pp.1230-1232, 2007. ,
Mechanism for the Endocytosis of Spherical Nucleic Acid Nanoparticle Conjugates, Proc. Natl. Acad. Sci, vol.110, pp.7625-7630, 2013. ,
Liposomal Spherical Nucleic Acids, J. Am. Chem. Soc, vol.136, issue.28, pp.9866-9869, 2014. ,
Topical Delivery of SiRNA-Based Spherical Nucleic Acid Nanoparticle Conjugates for Gene Regulation, Proc. Natl. Acad. Sci, vol.109, pp.11975-11980, 2012. ,
Topically Delivered Tumor Necrosis Factor-?-Targeted Gene Regulation for Psoriasis, J. Invest. Dermatol, vol.137, issue.9, pp.2027-2030, 2017. ,
Fomiversen Sodium Approved to Treat CMV Retinitis, J. Am. Pharm. Assoc. WashingtonDC, vol.39, issue.1, pp.84-85, 19961999. ,
Chapter 81 -HIV-Associated Infections, Retina ,
, , pp.1441-1472, 2013.
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform, Annu. Rev. Pharmacol. Toxicol, vol.50, issue.1, pp.259-293, 2010. ,
Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases, Neuron, vol.2017, issue.6, pp.1056-1070 ,
Antisense Oligonucleotides in Therapy for Neurodegenerative Disorders, Adv. Drug Deliv. Rev, vol.87, pp.90-103, 2015. ,
Nucleic Acid Nanomedicines in Phase II/III Clinical Trials: Translation of Nucleic Acid Therapies for Reprogramming Cells. Nanomed, 2018. ,
The Delivery of Therapeutic Oligonucleotides, Nucleic Acids Res, vol.44, issue.14, pp.6518-6548, 2016. ,
,
RNA-Targeted Therapeutics, Cell Metab, vol.27, issue.4, pp.714-739, 2018. ,
Geron Announces Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic Syndromes, 2018. ,
An Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia A and B, J. Blood Med, vol.9, pp.135-140, 2018. ,
,
, Nat. Rev. Drug Discov, vol.4, issue.3, pp.187-188, 2005.
,
Aptamer for Ocular Vascular Disease, Nat. Rev. Drug Discov, vol.5, issue.2, pp.123-132, 2006. ,
Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration. Ophthalmol. Eye Dis, vol.2, pp.75-83, 2010. ,
Mechanism and Clinical Status of Antisense Oligonucleotides and Duplex RNAs, Nucleic Acids Res, vol.46, issue.4, pp.1584-1600, 2018. ,
Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells, PLoS ONE, vol.2016, issue.9, p.11 ,
Suppressing Transthyretin Production in Mice, Monkeys and Humans Using 2nd-Generation Antisense Oligonucleotides, Amyloid Int. J. Exp. Clin. Investig. Off. J. Int. Soc. Amyloidosis, vol.23, issue.3, pp.148-157, 2016. ,
Safety and Efficacy of a TTR Specific Antisense Oligonucleotide in Patients with Transthyretin Amyloid Cardiomyopathy, Amyloid, vol.2017, issue.4, pp.217-223 ,
,
Update on the Clinical Utility of an RNA Interference-Based Treatment: Focus on Patisiran. Pharmacogenomics Pers, vol.10, pp.267-278, 2017. ,
Oligonucleotide Therapies: The Past and the Present, Hum. Gene Ther, vol.26, issue.8, pp.475-485, 2015. ,
Treatment of HCV Infection by Targeting Mi-croRNA, N. Engl. J. Med, vol.368, issue.18, pp.1685-1694, 2013. ,
Long-Term Safety and Efficacy of MicroRNA-Targeted Therapy in Chronic Hepatitis C Patients, Antiviral Res, vol.111, pp.53-59, 2014. ,
Phase I Study of MRX34, a Liposomal MiR-34a Mimic, Administered Twice Weekly in Patients with Advanced Solid Tumors, Invest. New Drugs, vol.35, issue.2, pp.180-188, 2017. ,
Reversal of SiRNA-Mediated Gene Silencing in Vivo, Nat. Biotechnol, vol.36, issue.6, pp.509-511, 2018. ,
Reversal of SiRNA-Mediated Gene Silencing in Vivo, Nat. Biotechnol, vol.36, issue.6, pp.509-511, 2018. ,
,
Polymer-drug Conjugates for Cancer Treatment: Realities, Insights, and Prospects Nat. Rev. Drug Disc, 2019. ,
Predoctoral and Postdoctoral Training Pipeline in Translational Biomaterials Research and Regenerative Medicine, ACS Biomater. Sci. Eng, 2017. ,